Rs 450 to Rs 4,200: Drugmakers rush in to win the business of losing weight

Competition in India's obesity drug market heats up as generic versions of popular weight-loss medications launch. Following patent expiry, multiple Indian drugmakers have released their versions. This move aims to increase accessibility in a price-sensitive nation. Experts anticipate significant market growth by 2030. However, concerns about potential misuse and confusion among doctors are also raised as prices fall.